BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1084212)

  • 1. Myocardial glycogen in prevention of perioperative ischemic injury of the heart: a preliminary report.
    Iyengar SR; Charrette EJ; Iyengar CK; Wasan S
    Can J Surg; 1976 May; 19(3):246-51. PubMed ID: 1084212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of preoperative myocardial glycogen levels in human cardiac preservation. Preliminary report.
    Lolley DM; Ray JF; Myers WO; Sautter RD; Tewksbury DA
    J Thorac Cardiovasc Surg; 1979 Nov; 78(5):678-87. PubMed ID: 315019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of glucose-insulin-potassium solution added to reperfusion treatment in acute myocardial infarction.
    Türel B; Gemici K; Baran I; Yeşilbursa D; Güllülü S; Aydinlar A; Serdar A; Kazazoğlu AR; Kumbay E; Cordan J
    Anadolu Kardiyol Derg; 2005 Jun; 5(2):90-4. PubMed ID: 15939681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of metabolic support with glucose-insulin-potassium for left ventricular pump failure after aortocoronary bypass surgery.
    Coleman GM; Gradinac S; Taegtmeyer H; Sweeney M; Frazier OH
    Circulation; 1989 Sep; 80(3 Pt 1):I91-6. PubMed ID: 2670331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical assessment of myocardial protection with blood-GIK solution].
    Koyama N; Watanabe Y; Yoshihara K; Tokuhiro K; Horikoshi J; Tanaka T; Shiono N; Kawamura K; Takanashi Y; Komatsu H
    Rinsho Kyobu Geka; 1989 Apr; 9(2):169-72. PubMed ID: 9301914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of glucose-insulin-potassium solution on cardiac cytokines and enzymes.
    Celkan MA; Kazaz H; Daglar B; Celik A; Koruk S; Kocoglu H
    Thorac Cardiovasc Surg; 2006 Dec; 54(8):532-6. PubMed ID: 17151968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of high dose glucose-insulin-potassium infusion in patients with acute ST-segment elevation myocardial infarction: analysis of 7510 patients in China as part of CREATE-ECLA study].
    Yang YM; Zhu J; Tan HQ; Liang Y; Zhang Y; Li Y; Li JD; Liu LS;
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(26):1806-10. PubMed ID: 19040013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of high-dose glucose-insulin-potassium on myocardial metabolism after coronary surgery in patients with Type II diabetes.
    Szabó Z; Arnqvist H; Håkanson E; Jorfeldt L; Svedjeholm R
    Clin Sci (Lond); 2001 Jul; 101(1):37-43. PubMed ID: 11410112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial protection of insulin and potassium in a porcine ischemia-reperfusion model.
    Oates A; Nubani R; Smiley J; Kistler L; Hughey S; Theiss P; Perez-Tamayo RA; Eiferman D; Lonchyna V; Higgins RS
    Surgery; 2009 Jul; 146(1):23-30. PubMed ID: 19541007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermittent aortic cross-clamping versus St. Thomas' Hospital cardioplegia in extensive aorta-coronary bypass grafting. A randomized clinical study.
    Flameng W; Van der Vusse GJ; De Meyere R; Borgers M; Sergeant P; Vander Meersch E; Geboers J; Suy R
    J Thorac Cardiovasc Surg; 1984 Aug; 88(2):164-73. PubMed ID: 6379305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of preoperative glucose-insulin-potassium on myocardial glycogen levels and on complications of mitral valve replacement.
    Oldfield GS; Commerford PJ; Opie LH
    J Thorac Cardiovasc Surg; 1986 Jun; 91(6):874-8. PubMed ID: 3520160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose substrate in myocardial protection.
    Salerno TA; Wasan SM; Charrette EJ
    J Thorac Cardiovasc Surg; 1980 Jan; 79(1):59-62. PubMed ID: 7350389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preconditioning with glucose-insulin-potassium solution and restoration of myocardial function during coronary surgery.
    Jovic M; Gradinac S; Lausevic-Vuk L; Nezic D; Stevanovic P; Milojevic P; Djukanovic B
    Gen Physiol Biophys; 2009; 28 Spec No():262-70. PubMed ID: 19893109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiologically tolerable insulin reduces myocardial injury and improves cardiac functional recovery in myocardial ischemic/reperfused dogs.
    Zhang HX; Zang YM; Huo JH; Liang SJ; Zhang HF; Wang YM; Fan Q; Guo WY; Wang HC; Gao F
    J Cardiovasc Pharmacol; 2006 Dec; 48(6):306-13. PubMed ID: 17204910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Myocardial metabolism during the pre-ischemic administration of metabolic myocardial protection in coronary surgical patients].
    Zwölfer W; Hiesmayr M; Holzinger C; Perger P; Coraim F; Haider W
    Anaesthesist; 1990 Oct; 39(10):481-6. PubMed ID: 2278366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose-insulin-potassium and tri-iodothyronine individually improve hemodynamic performance and are associated with reduced troponin I release after on-pump coronary artery bypass grafting.
    Ranasinghe AM; Quinn DW; Pagano D; Edwards N; Faroqui M; Graham TR; Keogh BE; Mascaro J; Riddington DW; Rooney SJ; Townend JN; Wilson IC; Bonser RS
    Circulation; 2006 Jul; 114(1 Suppl):I245-50. PubMed ID: 16820580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of glucose-insulin-potassium infusion on myocardial perfusion and left ventricular remodeling in patients treated with primary angioplasty for ST-elevation acute myocardial infarction.
    Bucciarelli-Ducci C; Bianchi M; De Luca L; Battagliese A; Di Russo C; Proietti P; Vizza CD; Fedele F
    Am J Cardiol; 2006 Nov; 98(10):1349-53. PubMed ID: 17134627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous glucose-insulin-potassium during off-pump coronary artery bypass surgery does not reduce myocardial injury.
    Shim YH; Kweon TD; Lee JH; Nam SB; Kwak YL
    Acta Anaesthesiol Scand; 2006 Sep; 50(8):954-61. PubMed ID: 16923090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events.
    Lazar HL; Chipkin SR; Fitzgerald CA; Bao Y; Cabral H; Apstein CS
    Circulation; 2004 Mar; 109(12):1497-502. PubMed ID: 15006999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response of hypertrophic heart myocardial glycogen to GIK and hypovolemic shock.
    Wittnich C; Trudel JL; Chiu RC
    Circ Shock; 1986; 19(4):423-8. PubMed ID: 2943528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.